- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
-
- 长期趋势：
已有200家主力机构披露2024-06-30报告期持股数据，持仓量总计2.35亿股，占流通A股55.14%
- 波段诊断：
-
技术面诊股
诊断结果：5.2技术面打败了83%的股票
技术面评分前10的股票
近期的平均成本为31.87元。
平均成本
近期的平均成本为32.58元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"32.58","date":1732091183,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2024.11.21","stock":"1.08","trade":"0.22","ind":"-0.07"},{"date":"2024.11.20","stock":"5.84","trade":"2.52","ind":"0.78"},{"date":"2024.11.19","stock":"0.86","trade":"2.19","ind":"1.90"},{"date":"2024.11.18","stock":"-2.92","trade":"-2.07","ind":"-1.91"},{"date":"2024.11.15","stock":"-0.48","trade":"-2.51","ind":"-2.62"},{"date":"2024.11.14","stock":"-2.43","trade":"-3.03","ind":"-2.83"},{"date":"2024.11.13","stock":"-0.37","trade":"-1.31","ind":"0.40"},{"date":"2024.11.12","stock":"0.85","trade":"0.55","ind":"-0.65"},{"date":"2024.11.11","stock":"0.73","trade":"2.28","ind":"2.03"},{"date":"2024.11.08","stock":"-1.98","trade":"-0.32","ind":"-0.66"},{"date":"2024.11.07","stock":"2.02","trade":"2.56","ind":"2.44"},{"date":"2024.11.06","stock":"-0.72","trade":"-0.13","ind":"-0.35"},{"date":"2024.11.05","stock":"1.62","trade":"2.58","ind":"3.22"},{"date":"2024.11.04","stock":"1.55","trade":"1.73","ind":"1.99"},{"date":"2024.11.01","stock":"-0.10","trade":"-1.43","ind":"-1.28"},{"date":"2024.10.31","stock":"-0.26","trade":"0.45","ind":"0.57"},{"date":"2024.10.30","stock":"-1.33","trade":"-1.33","ind":"-0.12"},{"date":"2024.10.29","stock":"-2.75","trade":"-3.08","ind":"-1.33"},{"date":"2024.10.28","stock":"0.47","trade":"1.23","ind":"0.62"},{"date":"2024.10.25","stock":"-2.69","trade":"1.14","ind":"1.71"},{"date":"2024.10.24","stock":"-1.89","trade":"1.77","ind":"-1.27"}]
博雅生物,深证成指,生物制品指数
压力支撑
该股压力位为32.38元，支撑位为31.66元。
[{"text":"\u538b\u529b\u4f4d","value":"32.38","date":1732118400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"31.66","date":1732118400,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.9资金面打败了12%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月21日 16:42
| 机构今日流向(万元) | -2566.03 | 机构5日流向(万元) | -5593.51 |
| 机构10日流向(万元) | -12534.28 | 机构20日流向(万元) | -16200.99 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加1795.95万股，其中基金净减仓7家，主力净减仓5家，暂未发现中长期投资价值。
截止2024-06-30，共200家主力机构（基金195家，一般法人4家，QFII1家），持仓量总计23488.24万股，占流通A股55.14%
其中，基金持仓与2023-12-31相比：
增仓：47家 ，增持 997.62万股
减仓：54家 ，减持 1217.25万股
新出现在主力名单中：84家 ，持有2201.27万股
从主力名单中消失：89家 ，原持有616.42万股
其中，基金持仓与2023-12-31相比：
增仓：47家 ，增持 997.62万股
减仓：54家 ，减持 1217.25万股
新出现在主力名单中：84家 ，持有2201.27万股
从主力名单中消失：89家 ，原持有616.42万股
消息面诊股
诊断结果：5.6消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 博雅生物：11月20日获融资买入4017.91万元
2024-11-21 - 博雅生物：公司目前暂无回购计划
2024-11-20 - 南方医药保健灵活配置混合A重仓股博雅生物涨5.84
2024-11-20 - 2024年11月20日早间个股预警：迈信林股东至辉
2024-11-20 - 博雅生物：11月19日获融资买入1658.61万元
2024-11-20 - 博雅生物：7830.86万股限售股于11月25日可
2024-11-19 - 博雅生物：11月18日融券卖出金额21.77万元，
2024-11-19 - 券商观点|医药生物行业跟踪周报：DRG/DIP2.
2024-11-18 - 券商观点|医药行业周报：政策边际改善信号显著，医药
2024-11-18 - 行业周报|生物制品指数跌-4.05%, 跑输上证指
2024-11-15
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2024-11-06 |
| 一般消息 | 高管变动 | 因工作调动原因 | 2024-10-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-09-27 |
| 一般消息 | 高管变动 | 工作调动原因 | 2024-09-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-08-24 |
| 利好 | 分红转增 | 10派1.60元(含税) | 2024-08-24 |
| 一般消息 | 募资投向 | 公司购买资产 | 2024-08-24 |
| 一般消息 | 募资投向 | 2024-08-23 | |
| 一般消息 | 高管变动 | 委员会调整 | 2024-07-16 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-12 |
| 利好 | 分红转增 | 10派3元(含税) | 2024-03-23 |
| 一般消息 | 重大事项 | 关联交易 | 2024-03-23 |
| 一般消息 | 重大事项 | 关联交易 | 2024-01-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了80%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2024.11.21","price":"-0.07","value":"0.22"},{"date":"2024.11.20","price":"0.78","value":"2.52"},{"date":"2024.11.19","price":"1.90","value":"2.19"},{"date":"2024.11.18","price":"-1.91","value":"-2.07"},{"date":"2024.11.15","price":"-2.62","value":"-2.51"},{"date":"2024.11.14","price":"-2.83","value":"-3.03"},{"date":"2024.11.13","price":"0.40","value":"-1.31"},{"date":"2024.11.12","price":"-0.65","value":"0.55"},{"date":"2024.11.11","price":"2.03","value":"2.28"},{"date":"2024.11.08","price":"-0.66","value":"-0.32"},{"date":"2024.11.07","price":"2.44","value":"2.56"},{"date":"2024.11.06","price":"-0.35","value":"-0.13"},{"date":"2024.11.05","price":"3.22","value":"2.58"},{"date":"2024.11.04","price":"1.99","value":"1.73"},{"date":"2024.11.01","price":"-1.28","value":"-1.43"},{"date":"2024.10.31","price":"0.57","value":"0.45"},{"date":"2024.10.30","price":"-0.12","value":"-1.33"},{"date":"2024.10.29","price":"-1.33","value":"-3.08"},{"date":"2024.10.28","price":"0.62","value":"1.23"},{"date":"2024.10.25","price":"1.71","value":"1.14"},{"date":"2024.10.24","price":"-1.27","value":"1.77"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 四环生物 | 38.20% | -0.92% | 5.0分 |
| 2 | 康希诺 | 20.11% | -4.32% | 4.9分 |
| 3 | 未名医药 | 18.11% | -1.39% | 4.6分 |
| 4 | 百普赛斯 | 17.87% | 1.00% | 4.9分 |
| 5 | 荣昌生物 | 16.39% | 1.64% | 4.3分 |
| 6 | 金迪克 | 15.37% | -3.87% | 4.7分 |
| 8 | 艾迪药业 | 9.94% | -2.11% | 4.4分 |
| 10 | 卫光生物 | 7.63% | 0.41% | 4.7分 |
| 12 | 诺唯赞 | 6.60% | -7.36% | 5.2分 |
| 14 | 通化东宝 | 6.07% | -2.13% | 5.0分 |
| 16 | 优宁维 | 5.18% | -6.20% | 4.7分 |
| 18 | 康泰生物 | 4.79% | -5.92% | 4.4分 |
| 20 | 东宝生物 | 4.11% | -0.89% | 4.9分 |
| 22 | 近岸蛋白 | 3.26% | -3.65% | 3.8分 |
| 24 | 万泽股份 | 2.81% | -6.26% | 4.8分 |
| 26 | 我武生物 | 1.42% | -5.18% | 4.2分 |
| 28 | 智翔金泰 | 0.79% | -6.26% | 3.7分 |
| 30 | 安科生物 | 0.43% | -2.59% | 5.1分 |
| 32 | 诺诚健华 | 0.07% | 1.72% | 5.2分 |
| 34 | 赛升药业 | -0.87% | -1.60% | 4.5分 |
| 36 | 康弘药业 | -1.62% | 0.40% | 5.3分 |
| 38 | 西藏药业 | -2.15% | -3.71% | 4.8分 |
| 40 | 万泰生物 | -2.43% | -4.64% | 4.2分 |
| 42 | 双成药业 | -3.06% | 13.68% | 4.3分 |
| 44 | 君实生物 | -4.31% | -2.40% | 5.0分 |
| 46 | 百奥泰 | -6.00% | -7.62% | 3.5分 |
| 48 | 甘李药业 | -7.60% | -2.89% | 4.0分 |
| 50 | 赛伦生物 | -8.95% | -6.17% | 3.9分 |
| 52 | 科兴制药 | -9.89% | -4.65% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 18/73 ， 36/73。
[{"date":"2024-09-30","value":"5.54","vol":"1.38"},{"date":"2024-06-30","value":"4.27","vol":"0.75"},{"date":"2024-03-31","value":"2.06","vol":"0.43"},{"date":"2023-12-31","value":"3.27","vol":"1.90"},{"date":"2023-09-30","value":"6.30","vol":"3.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.54 | 4.27 | 2.06 | 3.27 | 6.30 |
| 行业(%) | 1.38 | 0.75 | 0.43 | 1.90 | 3.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"66.67","vol":"70.59"},{"date":"2024-06-30","value":"67.03","vol":"69.95"},{"date":"2024-03-31","value":"67.79","vol":"70.47"},{"date":"2023-12-31","value":"52.76","vol":"69.93"},{"date":"2023-09-30","value":"50.04","vol":"69.71"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
66.67 | 67.03 | 67.79 | 52.76 | 50.04 |
| 行业(%) | 70.59 | 69.95 | 70.47 | 69.93 | 69.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，两项指标的行业排名分别为 49/73 ， 30/73。
[{"date":"2024-09-30","value":"-43.16","vol":"173.80"},{"date":"2024-06-30","value":"-41.87","vol":"17.95"},{"date":"2024-03-31","value":"-44.36","vol":"29.19"},{"date":"2023-12-31","value":"-3.87","vol":"18.84"},{"date":"2023-09-30","value":"5.17","vol":"15.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-43.16 | -41.87 | -44.36 | -3.87 | 5.17 |
| 行业(%) | 173.80 | 17.95 | 29.19 | 18.84 | 15.35 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-11.07","vol":"-54.20"},{"date":"2024-06-30","value":"-3.05","vol":"-10.79"},{"date":"2024-03-31","value":"-10.74","vol":"-528.49"},{"date":"2023-12-31","value":"-45.06","vol":"-34.06"},{"date":"2023-09-30","value":"10.95","vol":"272.44"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-11.07 | -3.05 | -10.74 | -45.06 | 10.95 |
| 行业(%) | -54.20 | -10.79 | -528.49 | -34.06 | 272.44 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 35/73 ， 25/73。
[{"date":"2024-09-30","value":"0.16","vol":"0.22"},{"date":"2024-06-30","value":"0.11","vol":"0.14"},{"date":"2024-03-31","value":"0.06","vol":"0.07"},{"date":"2023-12-31","value":"0.33","vol":"0.33"},{"date":"2023-09-30","value":"0.27","vol":"0.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.11 | 0.06 | 0.33 | 0.27 |
| 行业(次) | 0.22 | 0.14 | 0.07 | 0.33 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.70","vol":"0.87"},{"date":"2024-06-30","value":"0.52","vol":"0.55"},{"date":"2024-03-31","value":"0.26","vol":"0.26"},{"date":"2023-12-31","value":"2.05","vol":"1.31"},{"date":"2023-09-30","value":"1.76","vol":"0.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.70 | 0.52 | 0.26 | 2.05 | 1.76 |
| 行业(次) | 0.87 | 0.55 | 0.26 | 1.31 | 0.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"14.53","vol":"-28.68"},{"date":"2024-06-30","value":"19.63","vol":"-36165.87"},{"date":"2024-03-31","value":"27.62","vol":"-43943.29"},{"date":"2023-12-31","value":"25.14","vol":"-170.97"},{"date":"2023-09-30","value":"20.40","vol":"-29016.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 14.53 | 19.63 | 27.62 | 25.14 | 20.40 |
| 行业 | -28.68 | -36165.87 | -43943.29 | -170.97 | -29016.32 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.99","vol":"2.73"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.77","vol":"2.86"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.99 | - | 0.77 | - |
| 行业 | 0.00 | 2.73 | 0.00 | 2.86 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/73 ， 45/73。
[{"date":"2024-09-30","value":"12.01","vol":"7.11"},{"date":"2024-06-30","value":"13.08","vol":"6.99"},{"date":"2024-03-31","value":"14.08","vol":"8.01"},{"date":"2023-12-31","value":"14.08","vol":"7.53"},{"date":"2023-09-30","value":"11.47","vol":"8.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
12.01 | 13.08 | 14.08 | 14.08 | 11.47 |
| 行业 | 7.11 | 6.99 | 8.01 | 7.53 | 8.24 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"10.84","vol":"5.73"},{"date":"2024-06-30","value":"11.94","vol":"5.87"},{"date":"2024-03-31","value":"12.86","vol":"6.87"},{"date":"2023-12-31","value":"12.85","vol":"6.45"},{"date":"2023-09-30","value":"10.42","vol":"7.25"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
10.84 | 11.94 | 12.86 | 12.85 | 10.42 |
| 行业 | 5.73 | 5.87 | 6.87 | 6.45 | 7.25 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 43/73 ， 43/73。
[{"date":"2024-09-30","value":"7.06","vol":"24.72"},{"date":"2024-06-30","value":"6.71","vol":"24.44"},{"date":"2024-03-31","value":"6.51","vol":"23.84"},{"date":"2023-12-31","value":"6.49","vol":"23.96"},{"date":"2023-09-30","value":"7.46","vol":"22.75"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
7.06 | 6.71 | 6.51 | 6.49 | 7.46 |
| 行业(%) | 24.72 | 24.44 | 23.84 | 23.96 | 22.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.08","vol":"0.40"},{"date":"2024-06-30","value":"0.07","vol":"0.38"},{"date":"2024-03-31","value":"0.07","vol":"0.36"},{"date":"2023-12-31","value":"0.07","vol":"0.35"},{"date":"2023-09-30","value":"0.08","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.08 | 0.07 | 0.07 | 0.07 | 0.08 |
| 行业(%) | 0.40 | 0.38 | 0.36 | 0.35 | 0.32 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 招商证券 | 2024-11-09 | 买入 | 买入 |
| 中邮证券 | 2024-11-01 | 买入 | 买入 |
| 野村东方国际证券 | 2024-11-01 | 增持 | 增持 |
| 华源证券 | 2024-10-30 | 买入 | 买入 |
| 万联证券 | 2024-10-30 | 买入 | 买入 |
| 东海证券 | 2024-10-29 | 买入 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"2.60","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"3.45","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.32","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.37","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.55","blueLineValue":"1.10","type":"YC"}]